These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 7788039)
21. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers. Koskinen P; Kovanen PT; Tuomilehto J; Manninen V Arch Intern Med; 1992 Jan; 152(1):90-6. PubMed ID: 1728934 [TBL] [Abstract][Full Text] [Related]
22. [Hypoalphalipoproteinemia and atherosclerosis. Genetic and biochemical profile of 10 families]. Ahumada Ayala M; Jiménez Villanueva C; Cardoso Saldaña G; Sienra Pérez JC; Zamora González J; Posadas Romero C Arch Inst Cardiol Mex; 1989; 59(1):9-18. PubMed ID: 2486742 [TBL] [Abstract][Full Text] [Related]
23. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. Gaziano JM; Buring JE; Breslow JL; Goldhaber SZ; Rosner B; VanDenburgh M; Willett W; Hennekens CH N Engl J Med; 1993 Dec; 329(25):1829-34. PubMed ID: 8247033 [TBL] [Abstract][Full Text] [Related]
24. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate. Nye ER; Sutherland WH; Temple Wa N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550 [TBL] [Abstract][Full Text] [Related]
25. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil. Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163 [TBL] [Abstract][Full Text] [Related]
26. [Patients with familial combined hyperlipidemia and smoking]. Králíková E; Sobra J; Rames J Cas Lek Cesk; 1997 Jul; 136(14):439-42. PubMed ID: 9340188 [TBL] [Abstract][Full Text] [Related]
27. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526 [TBL] [Abstract][Full Text] [Related]
28. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia. Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106 [TBL] [Abstract][Full Text] [Related]
29. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases. Varthakavi P; Turakhia DP; Sharma S; Salgaonkar DS; Nihalani KD; Joshi VR J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473 [TBL] [Abstract][Full Text] [Related]
30. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status. Holtzman E; Rosenthal T; Goldbourt U; Segal P Isr J Med Sci; 1984 Dec; 20(12):1169-76. PubMed ID: 6519949 [TBL] [Abstract][Full Text] [Related]
31. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Rubins HB; Robins SJ; Collins D; Fye CL; Anderson JW; Elam MB; Faas FH; Linares E; Schaefer EJ; Schectman G; Wilt TJ; Wittes J N Engl J Med; 1999 Aug; 341(6):410-8. PubMed ID: 10438259 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for coronary artery disease in patients with acute myocardial infarction. Effects of age, sex and ethnicity. Eisenberg S; Ehrenfeld M; Friedman G; Friedlander Y Isr J Med Sci; 1981 May; 17(5):309-17. PubMed ID: 7263187 [TBL] [Abstract][Full Text] [Related]
34. [Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia]. Hrebícek J; Skottová N; Chmela Z; Hrbková M Cas Lek Cesk; 1995 Mar; 134(5):141-4. PubMed ID: 7728839 [TBL] [Abstract][Full Text] [Related]
35. Lipoproteins in the progeny of young men with coronary artery disease: children with increased risk. Lee J; Lauer RM; Clarke WR Pediatrics; 1986 Aug; 78(2):330-7. PubMed ID: 3737309 [TBL] [Abstract][Full Text] [Related]
36. Relationship of lipid disorders to coronary heart disease. Glueck CJ Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376 [TBL] [Abstract][Full Text] [Related]
37. Association between periodontal disease and acute myocardial infarction. Emingil G; Buduneli E; Aliyev A; Akilli A; Atilla G J Periodontol; 2000 Dec; 71(12):1882-6. PubMed ID: 11156045 [TBL] [Abstract][Full Text] [Related]
38. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144 [TBL] [Abstract][Full Text] [Related]
39. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788 [TBL] [Abstract][Full Text] [Related]
40. Diet and exercise and gemfibrozil therapy for the management of dyslipidemia: a CEN study. Clinical Experience Network. Stelmach WJ; Rush DR; Brucker PC; Schaefer EJ; Holverson HE; Kane WJ; Huffman BL J Fam Pract; 1993 Apr; 36(4):401-8. PubMed ID: 8463782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]